Literature DB >> 9696362

In situ hybridization: a possible diagnostic aid in leptomeningeal metastasis.

R J van Oostenbrugge1, A H Hopman, F C Ramaekers, A Twijnstra.   

Abstract

In this review we discuss the clinical features and pathophysiology of leptomeningeal metastasis (LM), and elaborate on diagnostic tools for the detection of this serious complication of cancer. Because of the low sensitivity of the cytologic examination, new diagnostic approaches have been developed. The in situ hybridization technique may prove to be a reliable and early test for the detection of LM.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696362     DOI: 10.1023/a:1005926624303

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  51 in total

1.  A standardized protocol for flow cytometric analysis of cells isolated from cerebrospinal fluid.

Authors:  R Dux; A Kindler-Röhrborn; M Annas; P Faustmann; K Lennartz; C W Zimmermann
Journal:  J Neurol Sci       Date:  1994-01       Impact factor: 3.181

2.  Leptomeningeal metastases: MR evaluation.

Authors:  D M Yousem; P M Patrone; R I Grossman
Journal:  J Comput Assist Tomogr       Date:  1990 Mar-Apr       Impact factor: 1.826

3.  Detection of DNA abnormalities by flow cytometry in cells from cerebrospinal fluid.

Authors:  E S Cibas; M G Malkin; J B Posner; M R Melamed
Journal:  Am J Clin Pathol       Date:  1987-11       Impact factor: 2.493

4.  The central nervous system in childhood leukemia. I. The arachnoid.

Authors:  R A Price; W W Johnson
Journal:  Cancer       Date:  1973-03       Impact factor: 6.860

5.  DNA single cell cytometry in lymphocytic pleocytosis of the cerebrospinal fluid.

Authors:  S Biesterfeld; B Bernhard; S Bamborschke; A Böcking
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Glucosephosphate isomerase as a CSF marker for leptomeningeal metastasis.

Authors:  H B Newton; M Fleisher; M K Schwartz; M G Malkin
Journal:  Neurology       Date:  1991-03       Impact factor: 9.910

7.  Cell surface markers for diagnosis of central nervous system involvement in lymphoproliferative diseases.

Authors:  J Ernerudh; T Olsson; G Berlin; B Gustafsson; H Karlsson
Journal:  Ann Neurol       Date:  1986-11       Impact factor: 10.422

8.  Detection of occult follicular lymphoma by specific DNA amplification.

Authors:  M Stetlet-Stevenson; M Raffeld; P Cohen; J Cossman
Journal:  Blood       Date:  1988-11       Impact factor: 22.113

9.  Diagnosis of lymphoma, leukemia, and metastatic tumor involvement of the cerebrospinal fluid by cytology and immunocytochemistry.

Authors:  E Tani; I Costa; E Svedmyr; L Skoog
Journal:  Diagn Cytopathol       Date:  1995-02       Impact factor: 1.582

10.  Polyradiculopathy in leptomeningeal metastasis: the role of EMG and late response studies.

Authors:  J G Kaplan; R K Portenoy; D R Pack; T DeSouza
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

View more
  6 in total

Review 1.  Leukemia and the nervous system.

Authors:  Marc C Chamberlain
Journal:  Curr Oncol Rep       Date:  2005-01       Impact factor: 5.075

2.  Leptomeningeal Neoplasms.

Authors:  Lauren E. Abrey
Journal:  Curr Treat Options Neurol       Date:  2002-03       Impact factor: 3.598

Review 3.  Leukemic and lymphomatous meningitis: incidence, prognosis and treatment.

Authors:  Marc C Chamberlain; Craig Nolan; Lauren E Abrey
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

Review 4.  Novel approaches to treating leptomeningeal metastases.

Authors:  Jai Grewal; Marlon Garzo Saria; Santosh Kesari
Journal:  J Neurooncol       Date:  2011-08-28       Impact factor: 4.130

Review 5.  Neoplastic meningitis.

Authors:  Ana Aparicio; Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

Review 6.  Neoplastic meningitis.

Authors:  Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.